186 related articles for article (PubMed ID: 29195664)
1. [Actinomycosis revealed by ulceration of the palate and gingiva].
Dessirier F; Arnault JP; Denamps J; Sevestre H; Attencourt C; Lok C
Ann Dermatol Venereol; 2018 Mar; 145(3):173-177. PubMed ID: 29195664
[TBL] [Abstract][Full Text] [Related]
2. Acute primary actinomycosis involving the hard palate of a diabetic patient.
de Andrade AL; Novaes MM; Germano AR; Luz KG; de Almeida Freitas R; Galvão HC
J Oral Maxillofac Surg; 2014 Mar; 72(3):537-41. PubMed ID: 24528563
[TBL] [Abstract][Full Text] [Related]
3. Actinomycotic ulcer of the oral mucosa: an unusual presentation of oral actinomycosis.
Alamillos-Granados FJ; Dean-Ferrer A; García-López A; López-Rubio F
Br J Oral Maxillofac Surg; 2000 Apr; 38(2):121-3. PubMed ID: 10864706
[TBL] [Abstract][Full Text] [Related]
4. [A case of esophageal actinomycosis in a patient with normal immunity].
Kim HS; Cheon JW; Kim MS; Jung CK; Kim KR; Choi JW; Kang DW; Kim SY
Korean J Gastroenterol; 2013 Feb; 61(2):93-6. PubMed ID: 23458987
[TBL] [Abstract][Full Text] [Related]
5. Laryngeal actinomycosis in an immunocompromised patient.
Patel S; Jaworek AJ; Patel V; Duckworth LV; Sawhney R; Chheda NN
J Voice; 2014 Nov; 28(6):838-40. PubMed ID: 24930374
[TBL] [Abstract][Full Text] [Related]
6. Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib.
Jansen YJ; Janssens P; Hoorens A; Schreuer MS; Seremet T; Wilgenhof S; Neyns B
Melanoma Res; 2015 Dec; 25(6):550-4. PubMed ID: 26512791
[TBL] [Abstract][Full Text] [Related]
7. Abdominal actinomycosis.
Mueller MC; Ihrler S; Degenhart C; Bogner JR
Infection; 2008 Mar; 36(2):191. PubMed ID: 18379724
[TBL] [Abstract][Full Text] [Related]
8. [Actinomycosic mycetoma of the foot in Morocco due to Actinomycetes viscosus].
Baha H; Khadir K; Hali F; Benchikhi H; Zeghwagh A; Zerouali K; Belabbes H; El Mdaghri N; Soussi MA; Marnissi F; Kadioui F
J Mycol Med; 2015 Mar; 25(1):76-80. PubMed ID: 25649200
[TBL] [Abstract][Full Text] [Related]
9. Actinomycotic osteomyelitis of a long bone in an immunocompetent adult: a case report and literature review.
Ryu DJ; Jeon YS; Kwon HY; Choi SJ; Roh TH; Kim MK
BMC Musculoskelet Disord; 2019 May; 20(1):185. PubMed ID: 31043170
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks.
Anforth R; Carlos G; Clements A; Kefford R; Fernandez-Peñas P
Br J Dermatol; 2015 Jan; 172(1):239-43. PubMed ID: 25040674
[TBL] [Abstract][Full Text] [Related]
12. Actinomycosis: An infrequent disease in renal transplant recipients?
Rousseau C; Piroth L; Pernin V; Cassuto E; Etienne I; Jeribi A; Kamar N; Pouteil-Noble C; Mousson C
Transpl Infect Dis; 2018 Dec; 20(6):e12970. PubMed ID: 30055044
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma.
Anforth RM; Blumetti TC; Kefford RF; Sharma R; Scolyer RA; Kossard S; Long GV; Fernandez-Peñas P
Br J Dermatol; 2012 Nov; 167(5):1153-60. PubMed ID: 22804352
[TBL] [Abstract][Full Text] [Related]
14. Incarcerated umbilical hernia as the debut of abdominal actinomycosis.
Orti-Rodríguez RJ; Díaz-Nieto R; Villar-Pastor CM; Lasso-Betancor CE; Alonso-Gómez J; Rufián-Peña S
Cir Cir; 2012; 80(1):76-80. PubMed ID: 22472158
[TBL] [Abstract][Full Text] [Related]
15. Improved overall survival in melanoma with combined dabrafenib and trametinib.
Robert C; Karaszewska B; Schachter J; Rutkowski P; Mackiewicz A; Stroiakovski D; Lichinitser M; Dummer R; Grange F; Mortier L; Chiarion-Sileni V; Drucis K; Krajsova I; Hauschild A; Lorigan P; Wolter P; Long GV; Flaherty K; Nathan P; Ribas A; Martin AM; Sun P; Crist W; Legos J; Rubin SD; Little SM; Schadendorf D
N Engl J Med; 2015 Jan; 372(1):30-9. PubMed ID: 25399551
[TBL] [Abstract][Full Text] [Related]
16. Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma.
Ramani NS; Curry JL; Kapil J; Rapini RP; Tetzlaff MT; Prieto VG; Torres-Cabala CA
Am J Dermatopathol; 2015 Aug; 37(8):e96-9. PubMed ID: 25839886
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma.
Carlos G; Anforth R; Clements A; Menzies AM; Carlino MS; Chou S; Fernandez-Peñas P
JAMA Dermatol; 2015 Oct; 151(10):1103-9. PubMed ID: 26200476
[TBL] [Abstract][Full Text] [Related]
18. A case of pelvic actinomycosis with hepatic actinomycotic pseudotumor.
Kim HS; Park NH; Park KA; Kang SB
Gynecol Obstet Invest; 2007; 64(2):95-9. PubMed ID: 17314488
[TBL] [Abstract][Full Text] [Related]
19. Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib.
Lacroix JP; Wang B
J Cutan Med Surg; 2017; 21(1):54-59. PubMed ID: 27624900
[TBL] [Abstract][Full Text] [Related]
20. Periapical actinomycosis.
Pasupathy SP; Chakravarthy D; Chanmougananda S; Nair PP
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22854234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
